Search
GRI Bio Inc
GRIAdd to Watchlist
1.870USD
+0.090+5.06%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
33.24KMarket Cap
LossP/E TTM
Risk Assessment
Currency: USD Updated: 2026-07-02The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Biotechnology & Medical Research domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for GRI Bio Inc. The Biotechnology & Medical Research industry's average is 3.36. The company's beta value is -1.18. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Beta vs S&P 500 index
-1.18
VaR
+13.04%
240-Day Maximum Drawdown
+94.78%
240-Day Volatility
+371.98%
Return
Best Daily Return
60 days
+8.50%
120 days
+10.55%
5 years
+2337.41%
Worst Daily Return
60 days
-18.97%
120 days
-22.74%
5 years
-68.95%
Sharpe Ratio
60 days
-1.12
120 days
-2.65
5 years
+0.28
Risk Assessment
Maximum Drawdown
240 days
+94.78%
3 years
+99.97%
5 years
+100.00%
Return-to-Drawdown Ratio
240 days
+0.03
3 years
-0.33
5 years
-0.20
Skewness
240 days
+15.46
3 years
+26.37
5 years
+33.36
Volatility
Realised Volatility
240 days
+371.98%
5 years
+263.62%
Standardised True Range
240 days
+30.58%
5 years
+268631.90%
Downside Risk-Adjusted Return
120 days
-297.57%
240 days
-297.57%
Maximum Daily Upside Volatility
60 days
+62.98%
Maximum Daily Downside Volatility
60 days
+63.82%
Liquidity
Average Turnover Rate
60 days
+4.43%
120 days
+21.74%
5 years
--
Turnover Deviation
20 days
-98.84%
60 days
-98.94%
120 days
-94.78%